Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Neurology|December 1, 2025
Brain MRI findings in patients with post COVID-19 condition: frequency and longitudinal changes in a nationwide cohort studyLiv Lygre Furevik, Oksana Lapina, Elisabeth Stokke Lindland, et al.Journal of Alzheimer'S Disease : JAD|August 23, 2017
Detecting At-Risk Alzheimer's Disease CasesTormod Fladby, Lene Pålhaugen, Per Selnes, et al.Nature Communications|April 4, 2024
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's diseaseFernando Gonzalez-Ortiz, Bjørn-Eivind Kirsebom, José Contador, et al.BMJ Open|March 8, 2024
Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocolBeatriz Padrela, Amnah Mahroo, Mervin Tee, et al.Nature Genetics|September 8, 2021
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's diseaseDouglas P Wightman, Iris E Jansen, Jeanne E Savage, et al.Journal of Alzheimer'S Disease : JAD|November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementiaJulie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.JAMA Psychiatry|January 22, 2025
Depressive Symptoms and Amyloid PathologyWietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.Pageof 6